Skip to content

Prospective study of Xiaoer Feireqing granules for respiratory tract infection-induced childhood bronchial asthma attack based on the China Children's Asthma Action Plan and real medical environment

Prospective study of Xiaoer Feireqing granules for respiratory tract infection-induced childhood bronchial asthma attack based on the China Children's Asthma Action Plan and real medical environment

Status
Recruiting
Phases
Phase 4
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100050969
Enrollment
Unknown
Registered
2021-09-08
Start date
2021-09-01
Completion date
Unknown
Last updated
2022-05-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bronchial asthma in children induced by respiratory tract infection

Interventions

adding Xiaoer Feireqing granules group:Nil
Standard treatment group:Nil

Sponsors

Shanghai Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
3 Years to 13 Years

Inclusion criteria

Inclusion criteria: 1. Belong to the group of children with asthma attack induced by respiratory tract infection. 2. Aged 3 to 13 years (<14 years old). 3. The informed consent process should comply with regulations. It is agreed to add Xiaoer Feireqing Granules to the test children. The test children aged 8 years and above should sign the informed consent form together with the test children, and the children under the age of 8 years old should sign the informed consent form by their legal guardian. 4. The patient and guardian agree to use the Leisure Breath APP.

Exclusion criteria

Exclusion criteria: 1. Other diseases that can cause asthma or difficulty breathing, such as bronchiolitis, pneumonia, etc. 2. Children with severe asthma attacks and entering the ''red zone'': (1) Severe cough, suffocation, dyspnea, positive three concave sign; (2) Difficulty walking, speaking, unable to lie down; (3) Nose flaring and cyanosis of lips; (4) Crying, restlessness, anxiety, lethargy, lethargy, and even confusion; (5) PEF <60% predicted value. 3. The researcher believes that it is not suitable to enter this study.

Design outcomes

Primary

MeasureTime frame
Asthma attack control time/ratio;

Countries

China

Contacts

Public ContactXue Zheng

Shanghai Hospital of Traditional Chinese Medicine

guanxiaoyu@zyyjypj.cn+86 18621905133

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026